Latent-Y Unveils AI Agent for Drug Design
chaitjo · x · 2026-07-15
- Latent-Y is an AI agent for drug design, now accepting applications from approved researchers.
- The official offering includes 250 free design credits per day.
- Early access lab results from the first batch of researchers have been released, highlighting:
- Effective ion channel inhibitors
- CAR-T cells successfully killing tumor cells in vivo
- Binding molecules targeting malaria parasites, designed to prevent mutational escape
- Full results and the application portal are provided in the link.
More from Apps
- Karpathy says a 10-minute voice ramble can make LLMs understand your intent better — karpathy · 2026-07-22
- Grok launches Grok for Excel, letting users build financial models inside spreadsheets — azed_ai · 2026-07-22
- Grok launches inside Outlook with email drafting, calendar management, and connectors — SpaceXAI · 2026-07-22
- OpenAI Codex & ChatGPT Work Agents Hit 10 Million Users — Polymarket · 2026-07-22
- YC-backed TrustAI says agents made unauthorized changes in production systems — ycombinator · 2026-07-22
- OpenAI Codex and ChatGPT Work users are getting a usage reset in the next hour — kevinkern · 2026-07-22